Daily Equity Report 19 AUG 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 19 THAUGUST 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 37311.53 INDIAN EQUITY BENCHMARK - reversed morning losses to close marginally higher with the Nifty decisively holding 11,000 level, backed by banks and Benchmark indices NIFTY 11029.40 auto stocks. The BSE Sensex rose 38.80 points to 37,350.33 and the Nifty50 gained 18.40 points at 11,047.80. However, for the week, indices lost more than half a percent. GLOBAL FACE CLOSE PREVIOUS NIKKEI 20405.65 25495.46 1927.17 ! SECTORIAL INDICES Asian Market - Asian markets finished higher today with shares in Hong Kong leading the region. The Hang Seng is up 0.94% while China's Shanghai Composite is up 0.29% and CLOSE CNX 100 11154.55 Japan's Nikkei 225 is up 0.06%. S&P CNX 500 ! U.S. Market – North and South American markets finished mixed as of the most recent closing prices. The S&P 500 gained 0.25%, while the IPC led the Bovespa lower. They fell 2.29% and 1.20% respectively. CNX 200 BANK NIFTY 28217.00 ! TOP GAINERS European markets – European markets are broadly higher today with shares in France leading the region. The CAC 40 is CLOSE CHANGE (%) up 1.03% while Germany's DAX is up 1.03% and London's FTSE 100 is up 0.56%. UPL 551.00 MARUTI YESBANK TOP LOSERS CLOSE CHANGE (%) Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY SELL ON RISE SCRIPT CLOSE (%) 4.51 UPL PIVOT POINTS P 11013 S3 10724 S2 10869 S1 R1 11102 R2 11157 RESISTANCE R1-11180 R2-11300 R3 11302 2.46 GRASIM 10958 GAIL 2.21 SUPPORT S1-10900 S2-10800 1.57 CLOSE (%) -1.92 TCS -0.88 -0.86 -0.83 NET BUY (CR.) NET INSTITUTION SELL (CR) FII 5245.05 TREND STRATEGY SELL ON RISE 2765.88 PIVOT POINTS P 28110 SUPPORT NSE TOTALS S2 S1 27910 R2 R3 29230 DECLINE S 26990 27550 28470 28670 RESISTANCE R1-28500 R2-28700 INDICES BANK NIFTY NIFTY 1 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report ! ! Lupin receives USFDA approval for Hydrocortisone Valerate cream Hero MotoCorp manufacturing plants to remain shut for 4 days until August 18 The company stated in a filing to the exchanges on Friday that its manufacturing plants have been shut for four days till August 18 as part of annual routine as well as to adjust production with current market demand. Hero MotoCorp said its manufacturing facilities were closed from August 15 to 18, 2019. "While this has been part of the annual holiday calendar on account of Independence Day, Raksha Bandhan and the weekend, it also partly reflects the prevailing market demand scenario. This helps us to plan our production well in advance, thereby enabling us to stay flexible both in terms of volumes and production schedules," the company said.. Pharma major Lupin announced that it has received approval for its Hydrocortisone Valerate Cream USP, 0.2% from the United States Food and Drug Administration (USFDA). Lupins Hydrocortisone Valerate Cream USP, 0.2%, is the generic version of Westcort Cream, 0.2%, of Sun Pharmaceutical Industries, Inc. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adult patients. Hydrocortisone Valerate Cream USP, 0.2%, (RLD: Westcort) had annual sales of ~$15mn in the US, as per IQVIA MAT March 2019. ! Glenmark Pharma falls 5% as brokerages slash price targets Glenmark Pharma is currently down 5% after closing ~8% lower on Wedneday. Global brokerage house CLSA has maintained "sell" rating on Glenmark and cut the target price to Rs350/share from Rs500/share, according to media reports. CLSA stated that the consensus was underestimating the margin pressure from subdued revenue growth and high R&D spend. CLSA expects weak revenue growth along with a high R&D spend phase to keep margins muted. It has cut the FY20-FY21 EPS estimate by 15-18%. ! Moody's downgrades Indiabulls Housing Finance ratings; outlook changed to negative Shares Moody's Investors Service ("Moody's") has today downgraded Indiabulls Housing Finance Limited's (IBH) long term corporate family rating to Ba2 from Ba1. Moody's has also downgraded the company's foreign-currency senior secured rating to Ba2 from Ba1, foreign- and local- currency senior secured MTN program ratings to (P)Ba2 from (P)Ba1. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : APOLLOHOSP DATE : 19/08/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY APOLLOHOSP IN CASH ABOVE 1471 TGT 1500 SL 1440 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Tips Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.